Quick Answer
Instil Bio, Inc. reported Operating Income of -$78.58 million for fiscal year 2025.
Instil Bio, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$78.58M | -6.9% |
| 2024 | -$73.54M | +53.8% |
| 2023 | -$159.17M | +29.7% |
| 2022 | -$226.46M | -45.6% |
| 2021 | -$155.56M | -362.4% |
| 2020 | -$33.64M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$15.02M | +36.4% | +35.9% |
| June 30, 2025 | -$23.44M | -65.8% | +23.3% |
| March 31, 2025 | -$30.56M | -27.6% | -29.3% |
| September 30, 2024 | -$23.63M | +64.6% | -67.2% |
| June 30, 2024 | -$14.13M | +32.6% | +41.0% |
| March 31, 2024 | -$23.95M | +59.0% | +64.1% |
| September 30, 2023 | -$66.72M | -17.8% | -217.9% |
| June 30, 2023 | -$20.99M | +64.3% | +64.1% |
- Instil Bio, Inc. showed a decrease of -6.9% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, Instil Bio, Inc.’s operating income has declined by 133.6% (from -$33.64 million to -$78.58 million).
- The most recent figure is from Instil Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: